Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer Tomoko YanaiharaMasanori YokobaNoriyuki Masuda Original Article 11 July 2006 Pages: 419 - 427
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy Robert L. FineSamir S. ShahGregory Halligan Original Article 03 August 2006 Pages: 429 - 437
Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo Jing LinXiao-Jun YanHai-Min Chen Original Article 01 July 2006 Pages: 439 - 445
A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer Hideki UenoTakuji OkusakaSoh Saitoh Original Article 20 July 2006 Pages: 447 - 454
Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats Sherif Y. SaadMaha M. ArafahTawfeeg A. Najjar Original Article 20 July 2006 Pages: 455 - 460
Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates Stacie L. StapletonJoel M. ReidSusan M. Blaney Original Article 20 July 2006 Pages: 461 - 466
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors Matthew G. FuryDavid B. SolitNaiyer A. Rizvi Original Article 01 August 2006 Pages: 467 - 475
Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model Harikrishna DevalapallyDinesh ShenoyMansoor Amiji Original Article 22 July 2006 Pages: 477 - 484
Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide Shinya FujisawaRyuzo OhnoKazunori Ohnishi Original Article 26 August 2006 Pages: 485 - 493
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia Xianhua CaoLanyan FangDuxin Sun Original Article 12 August 2006 Pages: 495 - 505
Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST) Masafumi KawamuraMasatoshi GikaKoichi Kobayashi Original Article 08 August 2006 Pages: 507 - 513
Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells Junichi KurebayashiMamoru NukatsukaHiroshi Sonoo Original Article 10 August 2006 Pages: 515 - 525
Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1 Jason LongTejas ManchandiaJoya Chandra Original Article 19 August 2006 Pages: 527 - 535
In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases Scott A. ShafferCassie Baker-LeeJack W. Singer Original Article 19 August 2006 Pages: 537 - 548
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression Stephen ShibataWarren ChowJames Doroshow Original Article 19 October 2006 Pages: 549 - 557
Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies Sarah A. HolsteinHoward R. KnappRaymond J. Hohl Erratum 12 September 2006 Pages: 559 - 559